Contributor Page
Ropes & Gray LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 212 5969000
Fax: +1 212 5969090
1211 Avenue of the Americas
New York
New York
NY 10036-8704
United States
Awards
By Michael Littenberg, Andrew Dale, Amanda Raad, Julia Chen, Karen Oddo, Joanna Torode
In this Alert, we discuss the proposed legislation and provide a comparison to the UK and California modern slavery reporting requirements.
By Thomas N. Bulleit, David Peloquin, Elizabeth McCann, Nicholas Wallace
In a new advisory opinion, the U.S. Department of Health and Human Services Office of Inspector General clarified the scope of the Anti-Kickback Statute warranty safe harbor.
By Ropes & Gray LLP's Government Enforcement/White Collar Crime Practice
On September 13, 2017, President Donald Trump issued an Executive Order blocking investment firm, Canyon Bridge Capital Partners Inc., from acquiring Lattice Semiconductor Corporation.
By Paul S. Scrivano, Jane Goldstein, Sarah Young
Controlling stockholder buyouts of Delaware corporations are generally scrutinized under the lens of "entire fairness" to determine whether the transaction was the product of fair dealing and fair price.
By Rohan Massey
On 5 September 2017, in the case of Bărbulescu v Romania (Application no. 61496/08), the Grand Chamber of the European Court of Human Rights reversed a First Chamber decision and found that the Romanian courts, ...
By Leigh R. Fraser, Molly Moore
The Board of Governors of the Federal Reserve System has adopted final rules that represent a significant shift in the terms of over-the-counter derivatives, repurchase and reverse repurchase transactions...
By Scott A. McKeown
In Oil States, the "trial argument" is made to distinguish IPR proceedings from patent reexamination.
By Ropes & Gray LLP's Finance Practice
On July 27 of this year, Andrew Bailey, chief executive of the FCA, delivered a speech in which he questioned the sustainability of LIBOR in its current form.
By Scott A. McKeown
PTAB Expanded Panels Impact Less Than 1% of All AIA Trials
By Scott A. McKeown
An objection operates to preserve errors in admitting evidence. At the PTAB, the manner and timing of making evidentiary objections is governed by agency rule rather than the Federal Rules of Evidence (FRE).
By Scott A. McKeown
Article III Standing Only Necessary for Party Invoking Authority of Federal Courts
By Katherine Wang
In China, medical devices are divided into three regulatory classes based on the identified risks associated with the devices.
By Edward Black, Patrick J. Reinikainen
Having found that hiQ's claims were not preempted under the CFAA, the court then went on to address the potential merits of hiQ's claims under state law.
By Thomas N. Bulleit, Jessica M. Band, Katherine M. Sullivan
In the world of fee-for-service health care, most medical devices were sold to hospitals or other health care providers for use in the diagnosis or treatment of patients.
By Scott A. McKeown
Every so often a decision comes out of the USPTO's Patent Trial & Appeal Board (PTAB) or the Federal Circuit that has immediate value for patent prosecutors.
Contributor's Topics
More...